Literature DB >> 17453968

Cord blood volume reduction using an automated system (Sepax) vs. a semi-automated system (Optipress II) and a manual method (hydroxyethyl starch sedimentation) for routine cord blood banking: a comparative study.

V Lapierre1, N Pellegrini, I Bardey, C Malugani, P Saas, F Garnache, E Racadot, F Schillinger, S Maddens.   

Abstract

Background With the development of cord blood banking, solutions have to be found to solve the storage space problem, by reducing the volume of cord blood units (CBU). Methods We compared total nucleated cell (TNC) and CD34(+) cell counts before and after processing with three different CBU volume reduction methods used consecutively in our bank: a manual method based on hydroxyethyl starch sedimentation (HES) (n=447), a top-and-bottom (TB) semi-automated method (n=181) using Optipress II, and the Sepax automated method (n=213). Statistical analysis was done using t-tests, linear regression and Spearman correlation coefficients. Adjusted variables included TNC, CD34(+) cell counts, CD34(+) cell percentage and CB volume before processing. Results TNC recovery was higher with Sepax (80.3+/-7.7%) than with HES (76.8+/-9.1%) and TB (60.7+/-13.5%) (P<0.0001, both). It was higher with HES than with TB (P<0.0001). CD34(+) cell recovery was higher with Sepax (86+/-11.6%) than with HES (81.5+/-12.5%) and TB (82.0+/-17.7%) (P<0.008 and <0.0001, respectively) and results with HES and TB were not significantly different (P=0.7). Interestingly, with Sepax, TNC and CD34(+) cell recoveries were not correlated with pre-processing values (P=0.8 and 0.4, respectively). Discussion In conclusion, the Sepax volume reduction method allows higher TNC and CD34(+) cell recoveries.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17453968     DOI: 10.1080/14653240701196811

Source DB:  PubMed          Journal:  Cytotherapy        ISSN: 1465-3249            Impact factor:   5.414


  9 in total

1.  Trends in cord blood banking.

Authors:  Isidro Prat Arrojo; María del Carmen Hernández Lamas; Laura Ponce Verdugo; Pascual Rizo Alfaro; Rebeca Rodríguez Pena; Francisco Sánchez Gordo; Pilar Gómez Maldonado; Gracia García Gémar
Journal:  Blood Transfus       Date:  2011-11-15       Impact factor: 3.443

2.  Umbilical cord blood processing using Prepacyte-CB increases haematopoietic progenitor cell availability over conventional Hetastarch separation.

Authors:  C Basford; N Forraz; S Habibollah; K Hanger; C P McGuckin
Journal:  Cell Prolif       Date:  2009-09-15       Impact factor: 6.831

3.  Cell therapy of pseudarthrosis.

Authors:  Ricardo Bastos Filho; Simone Lermontov; Radovan Borojevic; Paulo Cezar Schott; Vinicius Schott Gameiro; José Mauro Granjeiro
Journal:  Acta Ortop Bras       Date:  2012       Impact factor: 0.513

4.  The cord blood separation league table: a comparison of the major clinical grade harvesting techniques for cord blood stem cells.

Authors:  Christina Basford; Nicolas Forraz; Saba Habibollah; Kendal Hanger; Colin McGuckin
Journal:  Int J Stem Cells       Date:  2010-05       Impact factor: 2.500

5.  Towards responsible cord blood banking models.

Authors:  P Rebulla; L Lecchi
Journal:  Cell Prolif       Date:  2011-04       Impact factor: 6.831

6.  Qualitative and quantitative cell recovery in umbilical cord blood processed by two automated devices in routine cord blood banking: a comparative study.

Authors:  Pilar Solves; Dolores Planelles; Vicente Mirabet; Amando Blanquer; Francisco Carbonell-Uberos
Journal:  Blood Transfus       Date:  2012-09-12       Impact factor: 3.443

7.  Effect of cord blood processing on transplantation outcomes after single myeloablative umbilical cord blood transplantation.

Authors:  Karen K Ballen; Brent R Logan; Mary J Laughlin; Wensheng He; Daniel R Ambruso; Susan E Armitage; Rachel L Beddard; Deepika Bhatla; William Y K Hwang; Joseph E Kiss; Gesine Koegler; Joanne Kurtzberg; Arnon Nagler; David Oh; Lawrence D Petz; Thomas H Price; Ralph R Quinones; Voravit Ratanatharathorn; J Douglas Rizzo; Kathleen Sazama; Andromachi Scaradavou; Michael W Schuster; Leonard S Sender; Elizabeth J Shpall; Stephen R Spellman; Millicent Sutton; Lee Ann Weitekamp; John R Wingard; Mary Eapen
Journal:  Biol Blood Marrow Transplant       Date:  2014-12-24       Impact factor: 5.742

8.  Clinical-grade generation of active NK cells from cord blood hematopoietic progenitor cells for immunotherapy using a closed-system culture process.

Authors:  Jan Spanholtz; Frank Preijers; Marleen Tordoir; Carel Trilsbeek; Jos Paardekooper; Theo de Witte; Nicolaas Schaap; Harry Dolstra
Journal:  PLoS One       Date:  2011-06-16       Impact factor: 3.240

9.  Human Leukocyte Antigen and Red Blood Cells Impact Umbilical Cord Blood CD34+ Cell Viability after Thawing.

Authors:  Diana Vanegas; Cristian-Camilo Galindo; Iván-Aurelio Páez-Gutiérrez; Lorena-Xiomara González-Acero; Pavel-Tiberio Medina-Valderrama; Juan-Camilo Lozano; Bernardo Camacho-Rodríguez; Ana-María Perdomo-Arciniegas
Journal:  Int J Mol Sci       Date:  2019-09-30       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.